Research Paper Volume 13, Issue 20 pp 23810—23830

CCR5 is a prognostic biomarker and an immune regulator for triple negative breast cancer

class="figure-viewer-img"

Figure 3.

Comparison of mutation (A) and CNV (B) landscapes between CCR5 high expression and low expression groups.